Point72 Asset Management
ATHE

Point72 Asset Management’s Alterity Therapeutics ATHE Stock Holding History

Point72 Asset Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-131,431
Closed -$537K – 2305
2025
Q2 		$537K Hold
131,431
– – ﹤0.01% 1763
2025
Q1 		$453K Buy
131,431
+98,804
+303% +$379K ﹤0.01% 1654
2024
Q4 		$108K Buy
+32,627
New +$51.8K ﹤0.01% 1958

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Point72 Asset Management's ATHE Position: Q3 2025 in Review

Point72 Asset Management sold out of Alterity Therapeutics (ATHE) in Q3 2025, closing a stake of 131,431 shares — an estimated $537K sold.

Point72 Asset Management first reported a position in ATHE in Q4 2024 and held it in 3 quarters. The position peaked at $537K in Q2 2025. 16 funds tracked by Wall St. Rank hold ATHE as of Q3 2025.

  • Point72 Asset Management reported no remaining Alterity Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Point72 Asset Management sold 131,431 Alterity Therapeutics shares in Q3 2025, an estimated $537K.
  • Point72 Asset Management first reported a position in Alterity Therapeutics in Q4 2024 and held it in 3 quarters.
  • Point72 Asset Management's Alterity Therapeutics position peaked at $537K in Q2 2025.
  • 16 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.